IL-17 Class Inhibitors and Plaque Psoriasis: Not All Biologics Relapse Equally
{{output}}
Objective: In patients with moderate-to-severe plaque psoriasis, recent meta-analyses compared efficacies among biologics and time to relapse after treatment withdrawal; however, there was notable heterogeneity in the clinical tr... ...